Challenges
Datasets
Workspaces
Papers
Discussions
Leaderboard
Log inSign up
Challenges
Datasets
Workspaces
Papers
Discussions
Leaderboard
Blog
Job Board
Q3AS

© 2026 Aqora Quantum S.A.S.

TermsPrivacyLegal Notice

Power System Technology

Quantum Computing in Pharmacology: Solving Complex Molecular Interactions

Khaled Fahd Al-Rashidi

Published Dec 21, 2024• 3 citations
Publisher

Abstract

Quantum computing, a revolutionary field in computational technology, holds immense potential for the future of pharmacology. By leveraging the principles of quantum mechanics, quantum computers can process complex calculations exponentially faster than classical computers. This capability is especially promising for understanding and solving complex molecular interactions, a crucial aspect of drug discovery, design, and development. In pharmacology, simulating molecular structures and interactions is often computationally expensive and time-consuming. Quantum computing can accelerate these processes, offering deeper insights into molecular behavior, enhancing drug efficacy, reducing side effects, and enabling the design of personalized medications. This article explores how quantum computing is poised to reshape pharmacology by improving molecular simulations, advancing drug discovery, and revolutionizing personalized medicine.

DOI
10.52783/pst.1218

Related papers

Quantum Computing in Biopharma: Redefining Molecular Design and Predictive Pharmacology

Pravin Puri, Prashant Kardile, Shyam Manza

The convergence of quantum computing (QC) and biopharmaceutical science promises to revolutionize molecular design and predictive pharmacology. Quantum computing — harnessing principles of superposition, entanglement and quantum algorithms — enables simulation of molecular interactions with a precision and scale beyond the reach of classical methods. This review outlines the fundamental principles of QC, discusses current applications in drug discovery and pharmacology, highlights hybrid quantum-classical approaches and quantum-machine learning (QML), and examines the challenges and future directions. The review suggests that, though currently at a nascent stage, QC could dramatically reduce drug development timelines, improve success rates, and pave the way for personalized medicine and complex biologics design.

•Dec 16, 2025•0 citations

Quantum Computing in Drug Discovery Techniques, Challenges, and Emerging Opportunities

Gomase VS, Arjun P. Ghatule, Rupali Sharma +1 more

INTRODUCTION: Quantum computing represents a transformative advancement in computational science, with applications in drug discovery, molecular interaction simulation, drug-target binding optimization, and the analysis of complex biological data at unprecedented speeds and accuracy. Quantum computing emerges as a powerful tool to accelerate the development of new therapeutics, drug design, and the simulation of complex chemical interactions, including personalized medicine strategies. The objective of this study is to explore the potential of quantum computing in drug discovery and development, highlighting its ability to reduce time and costs while accelerating the identification of promising drug candidates. METHODS: Quantum computing algorithms, such as Grover's algorithm and the Variational Quantum Eigensolver (VQE), are utilized to simulate molecular interactions of drugs and optimize drug design. In case studies, such as IBM's use of VQE for molecular simulations, these technologies demonstrate their effectiveness. RESULTS: Quantum computing has shown promise in addressing several technological barriers, such as lengthy development timelines and high costs. Additionally, demonstrated success in molecular simulations and solving challenges during the drug development process. However, challenges related to error rates, qubit coherence, and regulatory compliance remain. DISCUSSION: This study examines the applications of quantum computing in drug discovery, highlighting key techniques such as quantum simulation, quantum machine learning, and optimization algorithms. Quantum computing is crucial for interdisciplinary collaboration among quantum physicists, computational chemists, biologists, and pharmaceutical professionals, as it is essential to overcoming these obstacles and realizing the full potential of quantum technologies in medicine. CONCLUSION: Quantum computing holds great potential in drug discovery and development, offering accelerated, more accurate, and lower-cost research avenues, particularly in complex areas such as protein folding prediction and personalized medicine. This new paradigm has tremendous potential for guiding the future of pharmaceutical development and patient-focused medicine.

Current Drug Discovery Technologies•Sep 1, 2025•6 citations

Exploring the Potential of Quantum Computing for Drug Design

Surbhi Kamboj, Gorika Tomar, Archana Archana +5 more

Quantum AI, the integration of quantum computing and artificial intelligence, is revolutionizing drug design by addressing the limitations of traditional pharmaceutical development. This review explores its transformative potential in enhancing molecular simulations, structure-based, target-based, and ligand-based drug discovery, and personalized medicine. Quantum computing leverages principles like superposition, entanglement, and interference to perform complex calculations exponentially faster than classical systems, enabling precise modeling of molecular interactions. Algorithms such as the Variational Quantum Eigensolver (VQE) and Quantum Phase Estimation (QPE) outperform classical methods like Density Functional Theory (DFT) in accuracy and efficiency, facilitating the identification of promising drug candidates and optimizing their pharmacokinetic properties. Quantum AI also enhances personalized medicine by analyzing vast genomic datasets to tailor treatments, improving efficacy and minimizing adverse effects. Despite challenges, including noisy intermediate-scale quantum (NISQ) device limitations and the need for advanced error correction, ongoing research and interdisciplinary collaboration are driving progress. Quantum AI promises to reduce development costs, accelerate drug discovery, and democratize access to life-saving medications. By enabling simulation-based discovery and expanding drug-candidate libraries to include peptides and antibodies, it paves the way for breakthroughs in treating complex diseases. This review underscores the need for continued investment in quantum technology to fully harness its potential, positioning the pharmaceutical industry for a future where drug development is faster, more precise, and patient-centric, ultimately improving global healthcare outcomes.

Journal of Neonatal Surgery•May 9, 2025•0 citations

Quantum Computing in Pharmaceutical Science

Bancha Yingngam

In the field of pharmaceutical science, there is an increasing demand for advanced computational techniques to enhance drug discovery and understand complex molecular interactions. Classical models, despite their strengths, often struggle with complex biological systems and accurate drug predictions. Quantum computing, using qubits that exist in multiple states, processes information at unparalleled speeds. This chapter sheds light on the principles of quantum computing, emphasizing algorithms specifically designed for pharmaceutical applications. These methods signal groundbreaking advancements in drug design, molecular simulation, and drug interaction predictions. Quantum computers have the potential to surpass classical computers in simulating intricate molecules, thus offering more precise drug side effect forecasts. While challenges such as noise and error rates remain, the continuous evolution of quantum technology holds significant potential for breakthroughs in drug discovery and development.

Advances in computer and electrical engineering book series•Jan 31, 2024•3 citations

Quantum Computing in Drug Discovery: Revolutionizing Pharmaceutical Research

Anandhavalli Muniasamy

The integration of quantum computing in drug discovery has the potential to revolutionize pharmaceutical research by significantly enhancing molecular simulations, drug screening, and optimization processes. Traditional computational methods often struggle with the complexity of molecular interactions, leading to high costs and extended timelines in drug development. Quantum computing, with its ability to process complex calculations exponentially faster than classical computers, offers innovative solutions to these challenges. This chapter explores the fundamentals of quantum computing, its application in pharmaceutical research, and real-world case studies from leading organizations. It also discusses existing challenges, potential solutions, and future directions for adopting quantum computing in drug discovery. By addressing key technical, ethical, and regulatory aspects, this chapter provides a comprehensive analysis of how quantum technologies can accelerate and optimize the drug discovery pipeline.

IGI Global eBooks•Jul 11, 2025•8 citations

Accelerating Drug Development: The Role of Quantum Computing in Pharmaceutical Research

Minakshi Kommoju, Kanaka Durga Devi Nelluri, Vijaya Lakshmi Marella +6 more

The journey to develop drugs is long, time-consuming, and costly.Most drugs take years and billions of dollars before they hit the market.Traditional computations remain useful but have inadequacies to accurately reproduce molecular interactions and predict drug efficacy.Quantum computing represents a new tool to potentially revolutionize the challenges brought about by traditional computations in that it can more quickly and accurately solve several of these problems through applying the principles of quantum mechanics.This review examines the possibility of quantum computing to transform pharmaceutical research and drug development.The aim of this review is to give the reader an all-round perspective on the use of quantum computing in drug discovery, with its contributions to molecular modeling, drug-target interaction prediction, and pharmacological property optimization.It promises something new in the application of quantum algorithms to make up for the faults of classical methods used in pharmaceutical research.This review critically synthesizes a number of relevant studies that applied quantum computing capabilities to drug design.Particular attention is brought to quantum algorithms, including but not limited to VQE (Variational Quantum Eigensolver) and QAOA (Quantum Approximate Optimization Algorithm), in determining molecular structures in silico along with the capacity to predict chemical binding affinities.Secondly, the scope of the drugs-discovery application on the various platforms such as IBM Q versus Google Sycamore were compared with current classical computational approach.The quantum computer showed a lot of promise in the simulation of complicated molecular interactions faster than the classical counterparts.A lot of studies emphasize the accuracy quantum simulations have towards the prediction of drug-target binding mechanisms, and this makes the lead optimization process more efficient.However, with scalability and hardware issues, its application in the pharmaceutical research community is still yet to be wide-scale.Quantum computing promises to accelerate the drug development process by improving the speed and accuracy of molecular modeling and drug optimization.Although the field is still in its infancy, its integration into pharmaceutical research could lead to significant reductions in development time and cost.This review underlines the transformative potential of quantum computing and suggests future research directions for overcoming the current limitations and realizing its full potential in precision medicine.

Advances in health sciences research/Advances in Health Sciences Research•Jan 1, 2025•0 citations
Quantum computing, a revolutionary field in computational technology, holds immense potential for the future of pharmacology. By leveraging the principles of quantum mechanics, quantum computers can process complex calculations exponentially faster than classical computers. This capability is especially promising for understanding and solving complex molecular interactions, a crucial aspect of drug discovery, design, and development. In pharmacology, simulating molecular structures and interactions is often computationally expensive and time-consuming. Quantum computing can accelerate these processes, offering deeper insights into molecular behavior, enhancing drug efficacy, reducing side effects, and enabling the design of personalized medications. This article explores how quantum computing is poised to reshape pharmacology by improving molecular simulations, advancing drug discovery, and revolutionizing personalized medicine.
The convergence of quantum computing (QC) and biopharmaceutical science promises to revolutionize molecular design and predictive pharmacology. Quantum computing — harnessing principles of superposition, entanglement and quantum algorithms — enables simulation of molecular interactions with a precision and scale beyond the reach of classical methods. This review outlines the fundamental principles of QC, discusses current applications in drug discovery and pharmacology, highlights hybrid quantum-classical approaches and quantum-machine learning (QML), and examines the challenges and future directions. The review suggests that, though currently at a nascent stage, QC could dramatically reduce drug development timelines, improve success rates, and pave the way for personalized medicine and complex biologics design.
INTRODUCTION: Quantum computing represents a transformative advancement in computational science, with applications in drug discovery, molecular interaction simulation, drug-target binding optimization, and the analysis of complex biological data at unprecedented speeds and accuracy. Quantum computing emerges as a powerful tool to accelerate the development of new therapeutics, drug design, and the simulation of complex chemical interactions, including personalized medicine strategies. The objective of this study is to explore the potential of quantum computing in drug discovery and development, highlighting its ability to reduce time and costs while accelerating the identification of promising drug candidates. METHODS: Quantum computing algorithms, such as Grover's algorithm and the Variational Quantum Eigensolver (VQE), are utilized to simulate molecular interactions of drugs and optimize drug design. In case studies, such as IBM's use of VQE for molecular simulations, these technologies demonstrate their effectiveness. RESULTS: Quantum computing has shown promise in addressing several technological barriers, such as lengthy development timelines and high costs. Additionally, demonstrated success in molecular simulations and solving challenges during the drug development process. However, challenges related to error rates, qubit coherence, and regulatory compliance remain. DISCUSSION: This study examines the applications of quantum computing in drug discovery, highlighting key techniques such as quantum simulation, quantum machine learning, and optimization algorithms. Quantum computing is crucial for interdisciplinary collaboration among quantum physicists, computational chemists, biologists, and pharmaceutical professionals, as it is essential to overcoming these obstacles and realizing the full potential of quantum technologies in medicine. CONCLUSION: Quantum computing holds great potential in drug discovery and development, offering accelerated, more accurate, and lower-cost research avenues, particularly in complex areas such as protein folding prediction and personalized medicine. This new paradigm has tremendous potential for guiding the future of pharmaceutical development and patient-focused medicine.
Quantum AI, the integration of quantum computing and artificial intelligence, is revolutionizing drug design by addressing the limitations of traditional pharmaceutical development. This review explores its transformative potential in enhancing molecular simulations, structure-based, target-based, and ligand-based drug discovery, and personalized medicine. Quantum computing leverages principles like superposition, entanglement, and interference to perform complex calculations exponentially faster than classical systems, enabling precise modeling of molecular interactions. Algorithms such as the Variational Quantum Eigensolver (VQE) and Quantum Phase Estimation (QPE) outperform classical methods like Density Functional Theory (DFT) in accuracy and efficiency, facilitating the identification of promising drug candidates and optimizing their pharmacokinetic properties. Quantum AI also enhances personalized medicine by analyzing vast genomic datasets to tailor treatments, improving efficacy and minimizing adverse effects. Despite challenges, including noisy intermediate-scale quantum (NISQ) device limitations and the need for advanced error correction, ongoing research and interdisciplinary collaboration are driving progress. Quantum AI promises to reduce development costs, accelerate drug discovery, and democratize access to life-saving medications. By enabling simulation-based discovery and expanding drug-candidate libraries to include peptides and antibodies, it paves the way for breakthroughs in treating complex diseases. This review underscores the need for continued investment in quantum technology to fully harness its potential, positioning the pharmaceutical industry for a future where drug development is faster, more precise, and patient-centric, ultimately improving global healthcare outcomes.
In the field of pharmaceutical science, there is an increasing demand for advanced computational techniques to enhance drug discovery and understand complex molecular interactions. Classical models, despite their strengths, often struggle with complex biological systems and accurate drug predictions. Quantum computing, using qubits that exist in multiple states, processes information at unparalleled speeds. This chapter sheds light on the principles of quantum computing, emphasizing algorithms specifically designed for pharmaceutical applications. These methods signal groundbreaking advancements in drug design, molecular simulation, and drug interaction predictions. Quantum computers have the potential to surpass classical computers in simulating intricate molecules, thus offering more precise drug side effect forecasts. While challenges such as noise and error rates remain, the continuous evolution of quantum technology holds significant potential for breakthroughs in drug discovery and development.
The integration of quantum computing in drug discovery has the potential to revolutionize pharmaceutical research by significantly enhancing molecular simulations, drug screening, and optimization processes. Traditional computational methods often struggle with the complexity of molecular interactions, leading to high costs and extended timelines in drug development. Quantum computing, with its ability to process complex calculations exponentially faster than classical computers, offers innovative solutions to these challenges. This chapter explores the fundamentals of quantum computing, its application in pharmaceutical research, and real-world case studies from leading organizations. It also discusses existing challenges, potential solutions, and future directions for adopting quantum computing in drug discovery. By addressing key technical, ethical, and regulatory aspects, this chapter provides a comprehensive analysis of how quantum technologies can accelerate and optimize the drug discovery pipeline.
The journey to develop drugs is long, time-consuming, and costly.Most drugs take years and billions of dollars before they hit the market.Traditional computations remain useful but have inadequacies to accurately reproduce molecular interactions and predict drug efficacy.Quantum computing represents a new tool to potentially revolutionize the challenges brought about by traditional computations in that it can more quickly and accurately solve several of these problems through applying the principles of quantum mechanics.This review examines the possibility of quantum computing to transform pharmaceutical research and drug development.The aim of this review is to give the reader an all-round perspective on the use of quantum computing in drug discovery, with its contributions to molecular modeling, drug-target interaction prediction, and pharmacological property optimization.It promises something new in the application of quantum algorithms to make up for the faults of classical methods used in pharmaceutical research.This review critically synthesizes a number of relevant studies that applied quantum computing capabilities to drug design.Particular attention is brought to quantum algorithms, including but not limited to VQE (Variational Quantum Eigensolver) and QAOA (Quantum Approximate Optimization Algorithm), in determining molecular structures in silico along with the capacity to predict chemical binding affinities.Secondly, the scope of the drugs-discovery application on the various platforms such as IBM Q versus Google Sycamore were compared with current classical computational approach.The quantum computer showed a lot of promise in the simulation of complicated molecular interactions faster than the classical counterparts.A lot of studies emphasize the accuracy quantum simulations have towards the prediction of drug-target binding mechanisms, and this makes the lead optimization process more efficient.However, with scalability and hardware issues, its application in the pharmaceutical research community is still yet to be wide-scale.Quantum computing promises to accelerate the drug development process by improving the speed and accuracy of molecular modeling and drug optimization.Although the field is still in its infancy, its integration into pharmaceutical research could lead to significant reductions in development time and cost.This review underlines the transformative potential of quantum computing and suggests future research directions for overcoming the current limitations and realizing its full potential in precision medicine.